INNOVITA, kamfani ɗaya tilo na bincikar In-vitro a lardin Hebei, ya sami lambar yabo ta ƙasa.

A cikin Satumba 2020, Innovita (Tangshan) Biotechnology Co., Ltd.(INNOVITA) ta sami yabo a matsayin ƙungiyar ci gaba a yaƙin ƙasar da annobar Covid-19.Wannan shine kawai kamfanin bincike na In-vitro a Lardin Hebei don samun wannan karramawa.

"Bayan barkewar cutar ta Covid-19, Innovita (Tangshan) Biotechnology Co., Ltd. nan da nan ta dauki matakin don cin gajiyar fa'idodin fasaha na mai da hankali kan na'urorin gano cututtukan cututtukan numfashi na shekaru masu yawa, kuma cikin gaggawa ta tura manyan mutane don aiwatar da aikin. binciken kimiyya."INOVITA ya gabatar.

INNOVITA tana da ƙungiyar binciken kimiyya da ta ƙunshi PhDs da manyan ƙwararrun ma'aikata.Duk membobin ƙungiyar R&D sun ba da hutun su kuma sun dawo cibiyar R&D na kamfanin daga wurare daban-daban, sun dawo bakin aiki da wuri-wuri, kuma sun sadaukar da kansu ga bincike da haɓaka abubuwan ganowa na Covid-19.Yin tsere akan lokaci, tsere kan ƙwayar cuta mai saurin yaduwa, dogaro da fa'idodin fasaha na abubuwan gano cututtukan numfashi, haɗarin kamuwa da cutar, da shawo kan matsaloli daga gwajin albarkatun ƙasa da haɓaka aiwatarwa, zuwa tabbatarwa na asibiti, INNOVITA ta sami nasarar haɓaka 2019-nCoV Antibody. Gwajin Kit.

A ranar 9 ga Fabrairu, 2020, samfurin ya wuce ƙwarewar ƙwararrun Hukumar Abinci da Magunguna ta Ƙasa.A ranar 11 ga Fabrairu, Ma'aikatar Kimiyya da Fasaha ta gano shi a matsayin babban aikin bincike na ƙasa.A ranar 22 ga Fabrairu, INNOVITA ta haɓaka wani sabon nau'in kayan gwajin rigakafin 2019-nCoV, wanda ya bambanta da samfuran da aka bayyana da yawa a cikin ƙasar kuma ya zama ɗaya daga cikin kamfanoni biyu na farko a cikin ƙasar don samun takardar shaidar rajista don gwajin rigakafin Covid-19. reagents.Shahararrun ƙwararrun masana sun fahimci tasirin gwajin gwajin rigakafin INNOVITA 2019-nCov.

Ba kamar sanannun masu gano abubuwan gano acid nucleic na Covid-19 ba, INNOVITA ta ƙirƙiri sabon mai ganowa na Covid-19.A cikin gwajin gwajin, ana iya gano maganin rigakafi na lgM a cikin majiyyaci, kuma ana iya gano antibody na lgM a ranar 7th na kamuwa da cutar ko kuma ranar 3rd na farkon farawa, yana ba da ƙarin cikakkun bayanai don ganewar asibiti.